![André Gerth](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Career history of André Gerth
Former positions of André Gerth
Companies | Position | Start | End |
---|---|---|---|
VITA 34 AG | Chief Executive Officer | 2012-06-30 | 2017-06-11 |
Investor Relations Contact | 2012-06-30 | 2017-06-11 | |
Corporate Officer/Principal | 2012-05-31 | 2012-06-30 | |
BioPlanta GmbH
![]() BioPlanta GmbH Pharmaceuticals: OtherHealth Technology Part of Active Ownership Capital SARL, BioPlanta GmbH is a German company that researches, develops, and distributes botanical active agents for pharmaceutical purposes. The company is based in Leipzig, Germany. BioPlanta was acquired by Vita 34 AG on May 16, 2012 for $1.47 million. | Chief Executive Officer | 1991-12-31 | 2012-06-30 |
stellacure GmbH
![]() stellacure GmbH Medical/Nursing ServicesHealth Services stellacure GmbH provides cord blood and stem cell banking services. It specializes in the removal, processing, and deposit of stem cells from the umbilical cord blood. The firm also engages in partnerships with life sciences advisory firms and blood service units. The company was founded in 2006 and is headquartered in Leipzig, Germany. | Chief Executive Officer | - | - |
Training of André Gerth
Universität Leipzig | Doctorate Degree |
Statistics
International
Germany | 5 |
Operational
Chief Executive Officer | 3 |
Investor Relations Contact | 1 |
Corporate Officer/Principal | 1 |
Sectoral
Health Technology | 3 |
Consumer Services | 2 |
Health Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
VITA 34 AG | Health Technology |
Private companies | 2 |
---|---|
BioPlanta GmbH
![]() BioPlanta GmbH Pharmaceuticals: OtherHealth Technology Part of Active Ownership Capital SARL, BioPlanta GmbH is a German company that researches, develops, and distributes botanical active agents for pharmaceutical purposes. The company is based in Leipzig, Germany. BioPlanta was acquired by Vita 34 AG on May 16, 2012 for $1.47 million. | Health Technology |
stellacure GmbH
![]() stellacure GmbH Medical/Nursing ServicesHealth Services stellacure GmbH provides cord blood and stem cell banking services. It specializes in the removal, processing, and deposit of stem cells from the umbilical cord blood. The firm also engages in partnerships with life sciences advisory firms and blood service units. The company was founded in 2006 and is headquartered in Leipzig, Germany. | Health Services |
- Stock Market
- Insiders
- André Gerth
- Experience